Finance

Beta
Lists
IBIO:NASDAQ
Ibio Inc
$1.73
+0.08%
(+0.0014) 1D
Jun 30, 2:55:09 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBIO...
Open
$1.73
High
$1.75
Low
$1.70
Mkt. cap
86.01M
Avg. vol.
834.03K
Volume
244.90K
52-wk high
$3.82
52-wk low
$0.56
EPS
-$0.83
Beta
1.26
Shares outstanding
49.68M
No. of employees
20
Open
$1.73
High
$1.75
Low
$1.70
Mkt. cap
86.01M
Avg. vol.
834.03K
Volume
244.90K
52-wk high
$3.82
52-wk low
$0.56
EPS
-$0.83
Beta
1.26
Shares outstanding
49.68M
No. of employees
20
News stories
From sources across the web
About Ibio Inc
CEO-
Employees20
Founded2008
Headquarters-
SectorBiotechnology
Websiteibioinc.com
Analyst ratings
Based on 6 analysts giving stock ratings to IBIO in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IBIO in the last 3 months.
Highest
Current $1.73
$7.00 (+304.30%)
Average
$5.67 (+227.48%)
Lowest
$5.00 (+188.78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Martin Auster
Raymond James
Buy
Initiated
$5.00
+188.8%
06/08/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
$5.00
+188.8%
05/16/2026
Roanna Ruiz
Leerink Partners
Buy
Maintained
$6.00
+246.5%
05/15/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$6.00
+246.5%
05/14/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
$5.00
+188.8%
05/14/2026
Catherine Novack
JonesTrading
Buy
Maintained
$7.00
+304.3%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
200.00K
100.00K
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.22M
3.55M
4.28M
3.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.17M
2.50M
5.16M
5.11M
Operating expense
5.40M
6.05M
9.44M
8.36M
Total operating expenses
5.40M
6.05M
9.44M
8.36M
Operating income
-5.20M
-5.95M
-9.44M
-8.36M
Other non operating income
-
-
-
-
EBT including unusual items
-5.16M
-5.72M
-8.99M
-7.73M
EBT excluding unusual items
-5.16M
-5.72M
-8.99M
-7.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.16M
-5.72M
-8.99M
-7.73M
Net profit margin
-2,581.50%
-5,720.00%
-
-
Earnings per share
-0.32
-0.11
-0.09
-0.06
Interest and investment income
79.00K
267.00K
493.00K
657.00K
Interest expense
-44.00K
-36.00K
-41.00K
-22.00K
Net interest expenses
35.00K
231.00K
452.00K
635.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.00M
-5.76M
-9.30M
-8.21M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer